South Korea’s Rznomics inks $1.3 bn out-licensing deal with Eli Lilly

South Korea’s Rznomics inks $1.3 bn out-licensing deal with Eli Lilly

Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...

SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

Samsung Biologics wins another Eli Lilly COVID treatment order

Samsung Biologics wins another Eli Lilly COVID treatment order

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner